FDMT vs INTU · rev $37.0K vs P/E 64, rev $18.83B
4D Molecular Therapeutics Inc (FDMT) versus Intuit Inc (INTU) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Intuit Inc (INTU) is a software - application company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported INTU revenue for 2025-07-31 was $18.83B. Net income was $3.87B. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
FDMT currently screens at market cap $518.1M. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
Not investment advice. Open the FDMT and INTU stock pages for the full models.
Not investment advice.